BACKGROUND: Age-related macular degeneration (AMD) is the leading cause of blindness in the western world. To prevent what will certainly be a tremendous health and economic burden, effective therapeutics for AMD are urgently needed. To develop these agents in a timely fashion, the molecular pathways that cause disease progression must be elucidated. OBJECTIVE: To briefly describe the clinical features of AMD, and review the current understanding of the molecular basis of AMD. METHODS: A literature review. RESULTS: The discussion will primarily focus on the interplay of oxidative stress and complement dysregulation and the resulting chronic proinflammatory state thought to be central in AMD pathogenesis. CONCLUSIONS: Oxidative stress and complement dysregulation play a substantive role in the development of AMD.
No takes yet. Share an insight, caveat, or question.
Barnett et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: